Genocea Initiates a Phase 1/2a Study with its Therapeutic Vaccine Candidate for Herpes Simplex Virus-2 (HSV-2). Brennan CaruthersAugust 15, 2012 Facebook0 Twitter LinkedIn0 Reddit 0 Likes